Tirzepatide
A peptide associated with GIP and GLP-1 receptor signalling research.
What is it?
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors. These receptors are part of cellular signalling systems studied in metabolic research.
What does the research explore?
Cell-based receptor experiments examine differences in activity at GIP and GLP-1 receptors. Researchers investigate which signalling pathways are activated, rather than assuming that activity at two receptors is identical.
How to interpret the evidence
The named molecule and a finished, regulated medicine are different things. A research product is not a substitute for a prescribed medicine.
Study findings apply to the material and experimental conditions used by the researchers. They do not show that a PepVision product produces the same effects, or establish a personal-use dose.
Available presentation
Tirzepatide · 60 mg. Check the product page for current pricing and documentation.
Preparation and study protocols
Use a validated laboratory procedure for the exact material, solvent and study. Contact us for the available specification and lot documents. This overview does not prescribe a preparation method, administration route or dosing schedule.
Sources
For research purposes only. Not for human or animal consumption.